Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Biomea Fusion, Inc.
Market Cap
$93.99M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$91.68M
Operating Margin
0.00%
TTM Avg
-10.06%
3Y Avg
-113.57%
5Y Avg
-75.71%
Market Cap
$91.33M
Operating Margin
-37.64%
TTM Avg
-44.68%
3Y Avg
-118.22%
5Y Avg
-258.09%
Market Cap
$88.21M
Operating Margin
12.60%
TTM Avg
-0.11%
3Y Avg
-11.38%
5Y Avg
-8.86%
Market Cap
$87.86M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$100.37M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1310.83%
5Y Avg
-1301.48%
Market Cap
$86.69M
Operating Margin
7.31%
TTM Avg
8.88%
3Y Avg
-4.43%
5Y Avg
-3.84%
Market Cap
$84.75M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$84.70M
Operating Margin
29.69%
TTM Avg
-17.51%
3Y Avg
-923.94%
5Y Avg
-894.93%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | $93.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | -10.06% | -113.57% | -75.71% |
| electroCore, Inc. (ECOR)vs › | $91.33M | -37.64% | -44.68% | -118.22% | -258.09% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 12.60% | -0.11% | -11.38% | -8.86% |
| Cardiff Oncology, Inc. (CRDF)vs › | $87.86M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| Anixa Biosciences, Inc. (ANIX)vs › | $100.37M | 0.00% | 0.00% | -1310.83% | -1301.48% |
| CareCloud, Inc. (CCLD)vs › | $86.69M | 7.31% | 8.88% | -4.43% | -3.84% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $84.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $84.70M | 29.69% | -17.51% | -923.94% | -894.93% |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -5271.69% | -2635.84% | -2669.01% | -3573.08% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
